I'd like to frame things a bit more generally.
Overall, what you're describing is referred to as a null hypothesis significance test. these tests have been criticized (mostly in the psychology/psychiatry literature) for being prone to misinterpretation. however, if used carefully, they enable testing a variety of phenomena without necessarily even changing the statistical test of choice - i.e. you could still use a Mann-Whitney, or an ANOVA, or a good old t-test...rather the difference is with respect to how the hypotheses are framed:
Null Hypothesis (H0): mu1 - mu2 = 0.
Alternative Hypothesis (H1):
H1: mu1 - mu2 != 0
(two-tailed)
or if one-tailed:
H1: mu1 - mu2 < 0
or H1: mu1 - mu2 > 0
Depending on the exact nature of the comparison desired, people go with different approaches. One is called the two one-sided tests (TOST) procedure. With TOST, you conduct two tests to evaluate whether the true difference between groups is both less than and greater than the bounds of this equivalence margin. If both tests are significant, you can conclude that the groups are equivalent within the specified margin.
Another route is confidence intervals analysis. If the 95% CI for the 2 groups falls entirely within a practically insignifcant range of values, an argument can be made that the groups are not meaningfully different (which is not to say the two are similar or the same).
Finally, where matters of belief are concerned, a Bayesian framework is frequently helpful. Here, the belief structure shifts from believing A is more plausible to rejecting that belief fluidly and on a single continuum. This can help with a variety of non-standard hypothesis tests.
These tests, though criticized, were originally proposed for (and are still used for) controlling type I error rate, which I think fairly closely resembles your use case. In terms of looking specifically at chip-seq data, i might recommend you use, therefore, a package that has been developed, benchmarked, and so forth, specifically for this purpose. Consider, for example, RECAP.